Prognostic Risk for Prostate Cancer According to Secretor Status
Current Research in Health Sciences · 2024
DOI: 10.58613/crhs212 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Research in Health Sciences, 2024. Verfasst von Alphonsus Ogbonna Ogbuabor und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Prostrate cancer is a leading cause of cancer mortality in Nigerian males. The Prostate Specific Antigen (PSA) is known to be a specific marker for the diagnosis of prostate cancer.
Objective
To investigate the association between secretor status and prostate specific antigen levels among apparently healthy males. Materials and Methods: This was a cross sectional study of 120 serially recruited apparently healthy males aged 40 years and above. Blood group of the subjects were determined by the Tile Hemagglutination test, the secretor status by the Tube Hemagglutination test while the PSA level was determined by Sandwich Enzyme-Linked Immunosorbent Assay. Data was analyzed using the Statistical Package for Social Sciences Version 23. P < 0.05 was considered significant.
Result
41.7% of the subjects who are non-secretors have PSA values of 4ng/ml and above compared to 10.2% for secretors.
Conclusion
This finding suggests that individuals who are non-secretors may be at risk for developing prostate cancer compared to secretors.
Zitieren
APA
Ogbuabor, A. O., Aniagolu, M. O., & Onah, E. S. (2024). Prognostic Risk for Prostate Cancer According to Secretor Status. Current Research in Health Sciences. https://doi.org/10.58613/crhs212
Vancouver
Ogbuabor AO, Aniagolu MO, Onah ES. Prognostic Risk for Prostate Cancer According to Secretor Status. Current Research in Health Sciences. 2024. doi:10.58613/crhs212
BibTeX
@article{Ogbuabor2024,
author = {Ogbuabor, Alphonsus Ogbonna and Aniagolu, Miriam Obiageli and Onah, Emmanuel Sunday},
title = {Prognostic Risk for Prostate Cancer According to Secretor Status},
journal = {Current Research in Health Sciences},
year = {2024},
doi = {10.58613/crhs212}
}
EUVIMED